Boston, MA -- (SBWIRE) -- 12/03/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Solta Medical Inc(NASDAQ:SLTM), Allianz SE (ADR)(OTCMKTS:AZSEY), Monster Worldwide, Inc.(NYSE:MWW), Myriad Genetics, Inc.(NASDAQ:MYGN)
Solta Medical Inc(NASDAQ:SLTM) opened its shares at the price of $2.00 for the day. Its closing price was $2.11 after gaining +5.50% for the day. The company traded with the total volume of 1.12 million shares, while its average trading volume remained 619,053.00 shares. The beta of SLTM stands at 2.58. Solta Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets energy-based medical device systems for aesthetic applications primarily in North America, the Asia Pacific, Europe, and the Middle East.
For How Long SLTM will Fight for Profitability? Read This Trend Analysis report
Allianz SE (ADR)(OTCMKTS:AZSEY) percentage change plunged -0.92% to close at $17.29 with the total traded volume of 69,472.00 shares, and average volume of 198,312.00. The 52 week range of the stock remained $12.92 - $17.55, while its day lowest price was $17.29 and it hit its day highest price at $17.41. Allianz SE primarily provides property and casualty, and life/health insurance products to private and corporate customers worldwide.
Has AZSEY Found The Bottom And Ready To Gain Momentum? Find Out Here
Monster Worldwide, Inc.(NYSE:MWW) started its trading session with the price of $5.62 and closed at $5.46 by scoring -3.02%. MWW’s stocks traded with total volume of 2.86 million shares, while the average trading volume remained 2.19 million shares. The beta of MWW stands at 2.70. Day range of the stock was $5.43 -$5.65. Monster Worldwide, Inc., together with its subsidiaries, provides online and mobile employment solutions worldwide. It offers customized solutions and technologies across a range of public and private sectors.
Why Should Investors Buy MWW After the Recent Fall? Just Go Here and Find Out
Myriad Genetics, Inc.(NASDAQ:MYGN) ended its day with the loss of -9.31% and closed at the price of $26.98 after opening at $29.71. Stock traded during its last trading session with the total volume of 10.00 million shares, as compared to its average volume of 2.04 million shares. Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States.
Will MYGN Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)